Clinical trials
Terminated Triple Negative Breast Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ADC Therapeutics S.A. | 1 |
| Amgen | 1 |
| Ayala Pharmaceuticals, Inc, | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| ERYtech Pharma | 1 |
| Eli Lilly and Company | 1 |
| G1 Therapeutics, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Novartis Pharmaceuticals | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
| Melanoma | 3 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.